RLAY Relay Therapeutics, Inc.
Healthcare$14.17+4.73%ClosedMarket Cap: $2.71B
As of 2026-05-26
Analyst Consensus
Consensus
Buy
Target (Consensus)
$23.00
Target (Median)
$22.00
Target Range
$18.00 - $27.00
Upside from current price: 62.3%
Rating Distribution
2 Strong Buy11 Buy1 Hold0 Sell0 Strong Sell
Recent Analyst Ratings
| Date | Firm | Action | Rating | Previous |
|---|---|---|---|---|
| 2026-05-20 | Barclays | maintain | Overweight | Overweight |
| 2026-05-20 | Citizens | maintain | Market Outperform | Market Outperform |
| 2026-05-19 | Raymond James | maintain | Strong Buy | Strong Buy |
| 2026-04-29 | HC Wainwright & Co. | maintain | Buy | Buy |
| 2026-04-28 | Wells Fargo | maintain | Overweight | Overweight |
| 2026-04-28 | Oppenheimer | maintain | Outperform | Outperform |
| 2026-04-28 | Goldman Sachs | maintain | Buy | Buy |
| 2026-04-08 | Barclays | maintain | Overweight | Overweight |
| 2026-03-23 | HC Wainwright & Co. | maintain | Buy | Buy |
| 2026-03-17 | Citizens | maintain | Market Outperform | Market Outperform |
Forward Estimates
| Period | EPS Est. | Revenue Est. | # Analysts |
|---|---|---|---|
| Fri Dec 31 | $-1.66 | $19.6M | 7 |
| Sun Dec 31 | $-1.57 | $54.5M | 9 |
| Mon Dec 31 | $-1.07 | $182.6M | 3 |
| Tue Dec 31 | $-0.19 | $458.5M | 3 |